Prominent Players - Veterinary Dermatology Drugs Industry

Aug, 2023 - by CMI

Prominent Players - Veterinary Dermatology Drugs Industry

The Veterinary Dermatology Drugs market encompasses pharmaceuticals designed to treat skin conditions in animals. These drugs address various dermatological issues such as infections, allergies, and parasites affecting pets and livestock. Common medications include antibiotics, antifungal, corticosteroids, and parasiticides. The market’s growth is driven by rising pet ownership, increasing awareness of animal health, and advancements in veterinary medicine. Pharmaceutical companies continually develop new formulations to provide effective solutions for diverse dermatological problems in animals, contributing to the expansion of this specialized market.

According to Coherent Market Insights, The market for Veterinary Dermatology Drugs was estimated at US$ 2.43 billion in 2022 and is anticipated to grow at a CAGR of 7.67% from 2023 to 2030 to reach US$ 4.39 billion.

Key Competitors in the Veterinary Dermatology Drugs Industry:

1. Zoetis Inc.

Zoetis Inc., established in 2013 and headquartered in Parsippany, USA, specializes in animal health and veterinary dermatology drugs, conducted R&D, engaged in clinical trials, formed collaborations, and initiated educational efforts. Notable products include Cytopoint for atopic dermatitis and Sileo for noise aversion in dogs, launched in 2016.

2. Elanco Animal Health Incorporated

Elanco Animal Health Incorporated, established in 1954, is headquartered in Greenfield, Indiana, USA. It operates in numerous countries worldwide, including the United Kingdom, Germany, and Japan. Specializing in animal health, Elanco launched innovative veterinary dermatology drugs as galliprant, targeting osteoarthritis pain, Osurnia for ear infections, and Atopica, an immunosuppressant for atopic dermatitis in dogs.

3. Virbac

Established in 1968, Virbac specializes in veterinary dermatology drugs and products. Headquartered in Carros, France, the company operates in over 100 countries, with branches and subsidiaries in locations such as the United States, Brazil, and Australia. Virbac focuses on developing dermatology solutions for animals, including shampoos, creams, and sprays, backed by research, partnerships with experts, and global educational initiatives.

4. Bayer AG

Bayer AG, established in 1863 and headquartered in Leverkusen, Germany, specializes in pharmaceuticals, consumer health, and crop science. Their animal health division focuses on producing veterinary pharmaceuticals, including dermatology drugs, for animals. With a global presence in multiple countries, Bayer collaborates with veterinarians to provide dermatological solutions for pets, reflecting its commitment to animal well-being.

5. Ceva Sante Animale

Ceva Sante Animale, established in 1999, specializes in veterinary pharmaceuticals and offers dermatology solutions for animals. Headquartered in Libourne, France, ceva operates globally, providing products like pharmaceuticals and tropical to address dermatological issues in pets. The company collaborates with veterinarians, engages in research and innovation, and offers a comprehensive range of animal health products, including vaccines and nutrition.

6. Kindred Biosciences

Established in 2012, Kindred Biosciences specializes in veterinary therapeutics. Headquartered in San Francisco, USA, the company focuses on developing pharmaceuticals for pets. Notably, they announced plans to develop generic versions of ATOPICA and APOQUEL, commonly used in treating skin conditions and allergies in dogs. Their FDA-approved product Zimeta for fever control in horses showcases their commitment to animal health. Research and a diverse product pipeline demonstrate their dedication to providing solutions for veterinary dermatology.

*Definition- Veterinary Dermatology Drugs are medications used to treat skin conditions in animals, addressing issues like allergies, infections, and inflammation.

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.